Dataset Information

Targeting the pregnane X receptor using microbial metabolite mimicry.

ABSTRACT: The human PXR (pregnane X receptor), a master regulator of drug metabolism, has essential roles in intestinal homeostasis and abrogating inflammation. Existing PXR ligands have substantial off-target toxicity. Based on prior work that established microbial (indole) metabolites as PXR ligands, we proposed microbial metabolite mimicry as a novel strategy for drug discovery that allows exploiting previously unexplored parts of chemical space. Here, we report functionalized indole derivatives as first-in-class non-cytotoxic PXR agonists as a proof of concept for microbial metabolite mimicry. The lead compound, FKK6 (Felix Kopp Kortagere 6), binds directly to PXR protein in solution, induces PXR-specific target gene expression in cells, human organoids, and mice. FKK6 significantly represses pro-inflammatory cytokine production cells and abrogates inflammation in mice expressing the human PXR gene. The development of FKK6 demonstrates for the first time that microbial metabolite mimicry is a viable strategy for drug discovery and opens the door to underexploited regions of chemical space.

SUBMITTER: Dvorak Z

PROVIDER: S-EPMC7136958 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Targeting the pregnane X receptor using microbial metabolite mimicry.

Dvořák Zdeněk Z Kopp Felix F Costello Cait M CM Kemp Jazmin S JS Li Hao H Vrzalová Aneta A Štěpánková Martina M Bartoňková Iveta I Jiskrová Eva E Poulíková Karolína K Vyhlídalová Barbora B Nordstroem Lars U LU Karunaratne Chamini V CV Ranhotra Harmit S HS Mun Kyu Shik KS Naren Anjaparavanda P AP Murray Iain A IA Perdew Gary H GH Brtko Julius J Toporova Lucia L Schön Arne A Wallace Bret D BD Walton William G WG Redinbo Matthew R MR Sun Katherine K Beck Amanda A Kortagere Sandhya S Neary Michelle C MC Chandran Aneesh A Vishveshwara Saraswathi S Cavalluzzi Maria M MM Lentini Giovanni G Cui Julia Yue JY Gu Haiwei H March John C JC Chatterjee Shirshendu S Matson Adam A Wright Dennis D Flannigan Kyle L KL Hirota Simon A SA Sartor Ryan Balfour RB Mani Sridhar S

EMBO molecular medicine 20200310 4

The human PXR (pregnane X receptor), a master regulator of drug metabolism, has essential roles in intestinal homeostasis and abrogating inflammation. Existing PXR ligands have substantial off-target toxicity. Based on prior work that established microbial (indole) metabolites as PXR ligands, we proposed microbial metabolite mimicry as a novel strategy for drug discovery that allows exploiting previously unexplored parts of chemical space. Here, we report functionalized indole derivatives as fir ...[more]

PMID: 32153125

Similar Datasets

Project description:A key step in the Ebola virus (EBOV) replication cycle involves conformational changes in viral glycoprotein 2 (GP2) which facilitate host-viral membrane fusion and subsequent release of the viral genome. Ebola GP2 plays a critical role in virus entry and has similarities in mechanism and structure to the HIV gp41 protein for which inhibitors have been successfully developed. In this work, a putative binding pocket for the C-terminal heptad repeat in the N-terminal heptad repeat trimer was targeted for identification of small molecules that arrest EBOV-host membrane fusion. Two computational structure-based virtual screens of ∼1.7 M compounds were performed (DOCK program) against a GP2 five-helix bundle, resulting in 165 commercially available compounds purchased for experimental testing. Based on assessment of inhibitory activity, cytotoxicity, and target specificity, four promising candidates emerged with 50% inhibitory concentration values in the 3 to 26 μM range. Molecular dynamics simulations of the two most potent candidates in their DOCK-predicted binding poses indicate that the majority of favorable interactions involve seven highly conserved residues that can be used to guide further inhibitor development and refinement targeting EBOV.IMPORTANCE The most recent Ebola virus disease outbreak, from 2014 to 2016, resulted in approximately 28,000 individuals becoming infected, which led to over 12,000 causalities worldwide. The particularly high pathogenicity of the virus makes paramount the identification and development of promising lead compounds to serve as inhibitors of Ebola infection. To limit viral load, the virus-host membrane fusion event can be targeted through the inhibition of the class I fusion glycoprotein of Ebolavirus In the current work, several promising small-molecule inhibitors that target the glycoprotein GP2 were identified through systematic application of structure-based computational and experimental drug design procedures.

Dataset Information

Targeting the pregnane X receptor using microbial metabolite mimicry.

Publications

Targeting the pregnane X receptor using microbial metabolite mimicry.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets